Last reviewed: June 11, 2026
Last updated: June 11, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Millions of adults carry excess weight that increases their risk for heart disease, type 2 diabetes, and joint problems—yet many don't know they qualify for prescription GLP-1 medications. PlexusDx clarifies the medical criteria, lifestyle factors, and straightforward process that determines whether tirzepatide, semaglutide, or other peptide therapies are right for you.
Body Mass Index and Weight Requirements for GLP-1 Treatment
Body mass index (BMI) remains the primary measure doctors use to assess weight-related health risk and candidacy for GLP-1 medications. Adults with a BMI of 30 or higher are medically classified as obese and often qualify for treatment. Those with a BMI between 27 and 29.9 who also have weight-related health conditions—such as high blood pressure, elevated cholesterol, or prediabetes—typically meet eligibility standards as well. Your specific BMI threshold depends on your personal health history, not a single number.
PlexusDx evaluates your complete health profile during the initial consultation, not just your weight or BMI alone. Clinicians review whether your current weight meaningfully impacts your quality of life, functional ability, or disease risk. This individualized approach means that two people at identical weights may have different treatment recommendations based on their age, metabolic profile, and existing medical conditions. The goal is identifying patients who will benefit most from GLP-1 therapy.
Medical Conditions That Make You a Candidate for Tirzepatide and Semaglutide
Beyond weight alone, several health conditions make GLP-1 medications medically appropriate and often covered or justified under treatment protocols. Prediabetes, characterized by fasting glucose between 100–125 mg/dL, indicates that your body is losing its ability to regulate blood sugar and signals increased diabetes risk. Type 2 diabetes itself is a primary indication—GLP-1s lower A1C levels and reduce cardiovascular events in diabetic patients. Hypertension, dyslipidemia (abnormal cholesterol), and metabolic syndrome all create additional justification for weight loss therapy.
Sleep apnea, joint pain from osteoarthritis, and fatty liver disease are increasingly recognized as conditions where weight reduction directly improves outcomes. Polycystic ovary syndrome (PCOS) in women often responds well to GLP-1 treatment because these medications improve insulin sensitivity and hormonal balance. Even without a diagnosed disease, if your weight significantly restricts your daily activities—climbing stairs, playing with children, or walking without pain—you may qualify. PlexusDx clinicians assess your full clinical picture to determine whether tirzepatide injection or another GLP-1 option aligns with your health needs.
Age, Liver Function, and Medical History Factors for GLP-1 Eligibility
Age alone does not disqualify someone from GLP-1 treatment, but certain age-related health changes affect how PlexusDx evaluates safety and benefit. Adults over 65 with multiple chronic conditions require more careful assessment of drug interactions and kidney function, though many older patients tolerate GLP-1s well and achieve significant health improvements. Conversely, younger adults in their 20s and 30s with substantial weight-related metabolic dysfunction (such as early-onset type 2 diabetes or severe sleep apnea) are excellent candidates. Your actual age matters less than your current health status and your body's functional capability.
Liver and kidney function tests are reviewed before starting treatment because tirzepatide and semaglutide are metabolized by the liver and excreted through the kidneys. Patients with severe liver disease or end-stage kidney disease may not be appropriate candidates, though mild-to-moderate impairment does not automatically exclude treatment. History of medullary thyroid cancer or personal or family history of multiple endocrine neoplasia type 2 is a contraindication to GLP-1 use. PlexusDx requires recent bloodwork and a detailed medical history to ensure safe and effective treatment selection.
How PlexusDx Determines Your GLP-1 Medication Match Without Insurance
PlexusDx uses a streamlined telehealth consultation model that removes insurance barriers while maintaining rigorous medical evaluation. You complete a detailed health questionnaire covering weight history, current symptoms, past treatments, and medical conditions. A licensed clinician reviews your information, discusses your goals, and may order or request recent bloodwork (fasting glucose, lipid panel, liver and kidney function). This approach takes 48–72 hours and costs nothing upfront—you only pay for medication if you proceed with treatment.
Once approved, PlexusDx offers tirzepatide injection starting at $249 per month from licensed 503A compounding pharmacies, alongside semaglutide, oral options, and dual-compound GLP-Squared protocols. Your dose may need to go up as your body adjusts—your price won't. All medications are HSA/FSA eligible, and PlexusDx serves all 50 states with no membership fee. If you're interested in understanding your genetic predisposition to peptide therapy response, the Precision Peptide Genetic Test ($99 add-on after your first month) maps your unique pathways across 14 biological systems and 150+ insights to optimize long-term outcomes.
Common Reasons People Are Denied GLP-1 Treatment and How to Overcome Them
The most common reason for GLP-1 denial in traditional healthcare is lack of insurance coverage or high out-of-pocket costs—a barrier PlexusDx eliminates by offering affordable pricing directly. Some patients are told they're 'not overweight enough' despite having significant metabolic dysfunction; PlexusDx clinicians understand that BMI is one data point, not the only criterion. Previous failed weight loss attempts or yo-yo dieting history should never disqualify you—in fact, GLP-1s work through a different mechanism (appetite suppression and glucose regulation) than calorie-restriction alone, making them effective for people who've struggled repeatedly.
Mild gastrointestinal side effects in early trials sometimes discourage patients, but modern dosing protocols start low and titrate slowly, minimizing nausea and adjusting dosing based on individual tolerance. Rare contraindications—like personal medullary thyroid cancer history—are genuine exclusions, but the vast majority of overweight adults with metabolic risk factors are candidates. If you've been denied treatment elsewhere, PlexusDx's individualized assessment may reveal that you qualify; the company's clinician network takes a patient-centered rather than algorithm-first approach.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Do I need to have type 2 diabetes to qualify for GLP-1 medications like tirzepatide?
No. While diabetes is one clear indication, overweight or obese adults without diabetes who have weight-related health conditions—high blood pressure, prediabetes, high cholesterol, or sleep apnea—often qualify. PlexusDx evaluates your full health picture and may approve you even if your only concern is weight-related functional decline or future disease prevention.
What's the minimum BMI to start GLP-1 treatment through PlexusDx?
PlexusDx typically considers BMI 30 and above, or BMI 27–29.9 with weight-related health conditions, as qualifying ranges. However, exact requirements depend on your individual health history, age, and metabolic profile—not a single number. Your consultation clinician will assess whether GLP-1 treatment aligns with your specific situation.
How much does tirzepatide injection cost per month, and will the price increase if my dose increases?
Tirzepatide injection from PlexusDx starts at $249 per month. Your dose may need to go up as treatment progresses—your price won't. PlexusDx maintains flat monthly pricing across all dose levels, and the medication is HSA/FSA eligible with no insurance required.
Can I qualify for GLP-1 treatment if I've failed diet and exercise before?
Yes. Repeated weight loss and regain don't disqualify you—they actually suggest you may benefit from GLP-1 therapy. These medications work on appetite and glucose regulation, mechanisms different from willpower or calorie restriction alone. PlexusDx sees prior failed attempts as evidence that metabolic support may be necessary for lasting success.
How does the Precision Peptide Genetic Test help determine if I'm a good candidate for GLP-1 treatment?
The Precision Peptide Genetic Test ($99 add-on after first month) examines your genetic variants in GLP1R, GIPR, FTO, MC4R, and 10 other pathways across 14 systems and 150+ insights. While this test is not pharmacogenomic (it doesn't predict drug metabolism), it reveals your genetic predisposition to peptide pathway responsiveness, helping PlexusDx clinicians optimize your specific medication and long-term strategy.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
What’s the Max Dose of Semaglutide for Weight Loss?
Does Ozempic Help Mental Health? What You Need to Know